Cite
HARVARD Citation
Duthie, M. et al. (2020). A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA–SE) in healthy adults. Vaccine. 38 (7), pp. 1700-1707. [Online].